Rifaximin Modulates the Vaginal Microbiome and Metabolome in Women Affected by Bacterial Vaginosis

Ítems similars

• Efficacy of Rifaximin Vaginal Tablets in Treatment of Bacterial Vaginosis: a Molecular Characterization of the Vaginal Microbiota
  per: Cruciani, Federica, et al.
  Publicat: (2012)
• Development of a Microarray-Based Tool To Characterize Vaginal Bacterial Fluctuations and Application to a Novel Antibiotic Treatment for Bacterial Vaginosis
  per: Cruciani, Federica, et al.
  Publicat: (2015)
• Diversity of vaginal microbiome and metabolome during genital infections
  per: Ceccarani, Camilla, et al.
  Publicat: (2019)
• Dynamics of Vaginal Bacterial Communities in Women Developing Bacterial Vaginosis, Candidiasis, or No Infection, Analyzed by PCR-Denaturing Gradient Gel Electrophoresis and Real-Time PCR
  per: Vitali, Beatrice, et al.
  Publicat: (2007)
• Vaginal Microbiomes Associated With Aerobic Vaginitis and Bacterial Vaginosis
  per: Kaambo, Evelyn, et al.
  Publicat: (2018)